Post-election riots in Kenya kill 5
Police deployed tear gas against the protesters, while a standoff near Mathare resulted in two deaths. In 2007, the country was engulfed by post-election ethnic violence that left about 1,400 people dead.

Man Rushes Britney Spears' Stage In Las Vegas
The man's struggle with shirtless backup dancer lasted a matter of seconds, before he was hauled away from the stage. A man has been arrested on suspicion of trespass after allegedly invading the stage at a Britney Spears concert.

Kenya's Elections At A Glance
Many private and public sector workers have continued to stay at home pending the final declaration of the presidential result. By the evening, after multiple delays, the country's elections commission still had not made any announcements.

Markets Right Now: Stocks drop, led by technology companies
Investors instead turned to safe-haven assets such as gold, pushing it to a two-month high, and the Japanese yen JPY= rose. Fossil tumbled 25.1 percent after the watch maker said sales continued to weaken, falling short of analysts' estimates.

At least five people have died after having balloons surgically implanted in their stomachs to help them lose weight, according to reports.

The FDA has not identified a root cause for the patient deaths and can not "definitively attribute the deaths to the devices or the insertion procedures for these devices", according to an agency notice.

However, the agency has issued a warning to doctors treating patients with similar devices to monitor them closely. ReShape is committed to supporting the continued safe and effective use of the dual balloon and is proactively communicating with physicians about this FDA update.

In the treatment, a silicone balloon is inserted via the patient's throat into their stomach, then filled with a saline solution. The company also notes that some people - it does not say how many - died while using the device. One involves Orbera Intragastric Balloon System and the other involves ReShape Integrated Dual Balloon System.

The FDA warned that someone who has already had gastrointestinal surgery or who is "unwilling or unable to participate in a medically-supervised diet and behavior modification program" should not try either of the devices. It has not received any product liability claims in connection with the five deaths. It is meant to gather information about anything that happens while someone is using a device or drug, or soon after, so that investigators can determine cause and effect.

"Patient safety is a key priority in everything we do at Apollo Endosurgery and we take adverse event reporting obligations related to our products very seriously", said Apollo Endosurgery CEO Todd Newton in a statement. The FDA letter is an important reminder to the physician community that obesity is a serious disease and many obese patients are affected by one or more co-morbid conditions due to their obesity.